CD40LG and common variable immunodeficiency: In a multicenter cohort, nearly 10% of patients diagnosed with CVID were ultimately reclassified as having XLP1 following confirmation of genetic testing, mainly in male patients presenting with early-onset disease, elevated IgM levels, and lymphoproliferative complications [4].